Co-Investigator, JHU NIMH Therapeutics Core
Assistant Professor of Clinical Pharmacology, Johns Hopkins University
Namandjé N. Bumpus received a PhD in pharmacology from the University of Michigan and performed thesis research in the laboratory of Dr. Paul F. Hollenberg where she investigated the effect of a naturally occurring cytochrome P450 (CYP) 2B6 mutation on the ability of the enzyme to become inactivated by known inactivators of the wild-type enzyme.
As a postdoctoral fellow with Dr. Eric F. Johnson at The Scripps Research Institute, Namandjé studied the regulation of cyp4a and cyp4f genes in mice. Namandjé is currently an Assistant Professor in the Division on Clinical Pharmacology and her research program is focused on defining the role of drug metabolism and reactive metabolite formation in the toxicities associated with the use of non-nucleoside reverse transcriptase inhibitors to treat HIV-1.